BAHEAL® Home ECG Device Makes Its New Debut, Another Addition to the BAHEAL Medical Commercialization Platform
Amid the advancement of medical technology and the growing public demand for healthcare services, the development of home electrocardiogram (ECG) monitors has drawn widespread attention. However, meeting medical-grade standards has always been a challenge in the industry. Probing deeply into the current cardio-vascular diagnosis and treatment scenario and the urgent needs of patients, on September 27, 2023, Baheal Medical (301015.SZ) strategically unveiled its "black tech" product: the BAHEAL® Home ECG. This twelve-lead home ECG monitor can promptly detect myocardial ischemia, winning critical treatment time for patients with heart attacks.
In recent years, due to increased living standards and lifestyle changes, the incidence and mortality rates of cardiovascular diseases have been on an annual upward trend. The "China Cardiovascular Health and Disease Report 2022" shows that there are nearly 330 million cardiovascular patients in China, with the mortality rate ranked at the top, accounting for over 40% of the mortality rate from all diseases among the population. Of these, over one million new heart attack cases occur each year, and the rescue rate is less than 5%. For cardiovascular patients, cardiac monitoring is a crucial safeguard for maintaining daily health and a primary means of timely disease detection. Thus, it significantly contributes to preventing and treating cardiovascular diseases and seizing the "golden two hours" for heart attack treatment.
The BAHEAL® Home ECG is a twelve-lead home ECG monitor that meets medical-grade ECG standards, providing a diagnostic value equivalent to that of a hospital, and is suitable for outpatient cardiac monitoring of cardiovascular patients and high-risk groups. Unlike single-lead or three-lead products, in addition to detecting arrhythmias, the BAHEAL® Home ECG can promptly monitor issues like myocardial ischemia and heart attacks, thus gaining critical treatment time for heart attack patients. Currently, the BAHEAL® Home ECG has obtained a national invention patent and has passed the national Class II medical device qualification certification.
The BAHEAL® Home ECG is user-friendly. Users simply need to place the ECG monitor against their chest and operate it by hand to collect ECG data. It takes less than a minute to gather this data, and if any abnormality is detected, timely warnings are provided. Users can also consult with online doctors 24/7 through the "Baheal ECG" app, or obtain an ECG diagnostic report reviewed by a cardiologist from a top-tier hospital online through the "Doctor's Reading" feature.
In discussing the launch of the BAHEAL® Home ECG, Zhang Yuan, Vice President of Baheal Medical, stated that the mission of Baheal Medical is to optimize medical scenarios through technological innovation. This Home ECG is a vivid manifestation of this mission. Thanks to technological breakthroughs, it can monitor myocardial ischemia in a timely manner, providing early warnings for high-risk cardiovascular disease groups. This enables patients with myocardial infarction to receive timely and effective treatment at critical moments—a goal not only for Baheal Medical, but for the entire healthcare industry.
As a third-party commercialization platform specializing in the pharmaceutical industry, Baheal Medical has created and operated multiple well-known brands such as D·Cal, Mite, and Hylo Comod. In recent years, it has continued to deepen its arrangements in OTC and healthcare, OTX and prescription drugs, oncology drugs, and high-end medical devices. It also operates AtriCure's atrial fibrillation treatment devices and CHBiomedical's fully magnetic levitation artificial hearts in the cardiovascular device field. The launch of the BAHEAL Home ECG represents not only BAHEAL Medical's active exploration in the field of home medical devices but also an important extension of its product layout in the field of cardiovascular diseases.
In honor of the 24th World Heart Day, Baheal Medical has joined hands with Weibo Health to initiate the "Heart Care Action," providing the public with a series of educational sessions on cardiovascular diseases and free experience services. Shield life, beginning with the 'heart', where the essence of health takes its start！
